Synthetic cannabinoid (SCRA)
Unscheduled4-HTMPIPO
4-hydroxy-3,3,4-trimethyl-1-(1-pentylindol-3-yl)pentan-1-one
Aliases.4 HTMPIPO · UR-144 hydraté
A hydration product of UR-144 found in products sold online; pharmacology not characterised.
Updated on
Level of detail
Harm-reduction warning
No characterised human dose: animal / in vitro data only. Effect profile, safety margin and acute toxicity are not documented in human clinical practice. Extremely potent compound: severe effects, seizures and deaths reported in the literature.
Identifiers
- Formula
- C₂₁H₃₁NO₂
- Molar mass
- 329.24 g·mol⁻¹
- CAS
- 1445751-38-1
- PubChem CID
- 72720476
- Origin
- A wholly synthetic compound with no natural occurrence. It appears as a transformation product of UR-144 in preparations intended for the illicit market, rather than as a substance deliberately manufactured for itself.
- InChIKey
- GWHGUYKAGQLPTQ-UHFFFAOYSA-N
In plain terms
4-HTMPIPO is not a drug designed as such: it is what UR-144, a synthetic cannabinoid, becomes when a molecule of water opens its small ring. It was found in products sold online. Its effects have never been studied.
Receptors and activity
- CB1Aucune donnée de pharmacologie publiée in vitro ni in vivo pour ce composéAgonist
- CB2Aucune donnée disponibleAgonist
- Agonist
- Partial agonist
- Antagonist
- Modulator
- Inverse agonist
Hover over a row for the precise value (Ki, EC50…)
Subjective signature
Hover over an axis to read its definition.
- Calm20
- Clarity12
- Sleep20
- Appetite15
- High25
Editorial estimate, not clinical.
Pharmacology
4-HTMPIPO illustrates a barely visible phenomenon of the synthetic cannabinoid market: what a product contains is not always what its maker put into it. Kavanagh and colleagues analysed in 2013 products sold on the internet, in plant, resin and powder form, containing UR-144. They found six related compounds there, the most abundant being this one: the product of the addition of a molecule of water to the cyclopropane ring of UR-144, a transformation that opens that strained ring and converts it into a chain bearing a tertiary alcohol. The authors show that this compound is not itself stable: it cyclises into a dihydrofuran derivative, which re-forms depending on the acidity of the medium, and it also appears as an artefact during analysis by gas chromatography. Pyrolysis, that is what actually happens when the product is smoked, generates yet other molecules, common to this compound and to UR-144. The picture that emerges is that of an unstable mixture: what the user inhales is neither what was sold nor what was analysed. The pharmacological question remains entirely open, and that is the honest limit of this entry: no measurement of activity at cannabinoid receptors has been published for this compound. One can reason that opening the compact cyclopropane of UR-144 into a flexible, polar chain ought to reduce affinity, since that motif is precisely the one that anchors in the receptor pocket, but nothing has verified it.
Origin (pharmaceutical research → illicit market)
An entirely chemical origin, described here by class only. The molecule derives from UR-144 by opening of its cyclopropane ring under the effect of an addition of water, a reaction that turns the tetramethylcyclopropyl group into a pentanone chain bearing a tertiary alcohol. The rest of the structure is unchanged: a ketone at position 3 of an indole whose nitrogen bears a pentyl chain. Kavanagh and colleagues moreover describe its reversible cyclisation into dihydrofuran derivatives, and its transformation by pyrolysis.
Legal framework
France
A substance not listed by name in Annex IV of the arrêté of 22 February 1990. The family of indol-3-yl methanones added by the arrêté of 31 March 2017 targets compounds whose carbonyl bridge bears a naphthyl, a benzyl, a phenyl, a cyclopropyl or an adamantyl; the present compound, whose cyclopropane is precisely opened, bears at that position a hydroxylated aliphatic chain corresponding to none of those substituents. The molecule it derives from, UR-144, does by contrast fall within that family. This reading is structural and the legal assessment belongs to the competent authorities.
European Union
Not listed under the international conventions of 1961 and 1971. The compound has been detected in products marketed online under the heading of so-called legal substances. Its national status varies according to whether Member States adopt listing by name or generic definitions, and according to how the latter treat degradation products.
Sources: EUR-Lex, UNODC, CND, ANSM, IUPHAR/BPS, ChEBI, EUDA. Our method.
Structural classification
- Class
- Synthetic cannabinoid (SCRA)
- Origin
- A wholly synthetic compound with no natural occurrence. It appears as a transformation product of UR-144 in preparations intended for the illicit market, rather than as a substance deliberately manufactured for itself.
- Status
- Unscheduled
References
Structured data
- InChIKey
- GWHGUYKAGQLPTQ-UHFFFAOYSA-N
- SMILES
- CCCCCn1cc(C(=O)CC(C)(C)C(C)(C)O)c2ccccc21
- Formula
- C21H31NO2
- Molar mass
- 329.24 g·mol⁻¹
- CAS
- 1445751-38-1
- PubChem CID
- 72720476
LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.